FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...
We received an updated WNV package insert; please note the manufacturer and license number has been ...